NICE looks to make new treatment development more efficient

NICE is to partner with a number of organisations as part of a new public-private project which aims to identify activities that can make the development and regulation of medicines more efficient. The project, called the Accelerated Development of Appropriate Patient Therapies (ADAPT SMART) is funded by the EU Innovative Medicines Initiative and is a collaboration between 32 international partners that includes regulators, patients, academia and industry representatives. Such streamlining of the process is needed, as the journey from developing a new medicine to gaining authorisation and decisions on reimbursement and approval can take years to complete. As new medicines